TY - BOOK AU - Lomborg,Bjørn TI - RethinkHIV: smarter ways to invest in ending HIV in sub-saharan Africa SN - 9781139236805 (ebook) AV - RA643.86.A357 R48 2012 U1 - 362.19697/9200967 23 PY - 2012/// CY - Cambridge PB - Cambridge University Press KW - RethinkHIV (Project) KW - HIV infections KW - Africa, Sub-Saharan KW - Prevention KW - AIDS (Disease) KW - Cost effectiveness N1 - Title from publisher's bibliographic system (viewed on 05 Oct 2015); Foreword; Peter Piot --; Introduction; Bjørn Lomborg --; Part I; The Research; 1; Sexual transmission of HIV; Jere R. Behrman and Hans-Peter Kohler; 2; Prevention of non-sexual transmission of HIV; Lori A. Bollinger; 3; Treatment; Mead Oliver and Geoffrey P. Garnett; 4; Strengthening health systems; William P. McGreevey, with Carlos Avila and Mary Punchak; 5; Social policy interventions to enhance the HIV/AIDS response in sub-Saharan Africa; Ana Vassall, Michelle Remme, and Charlotte Watts; 6; Vaccine research and development; Robert Hecht and Dean T. Jamieson, with Jared Augenstein, Gabrielle Partridge and Kira Thorien --; Part II; Ranking the Opportunities; 7; -- Findings of the Nobel Laureate economist expert panel; Ernest Aryeetey [and others]; 7.1; Findings from African civil society; Bactrin Killingo [and others]; 7.2; Conclusion; Bjørn Lomborg N2 - Thirty years after the identification of the disease that became known as AIDS, humanitarian organizations warn that the fight against HIV/AIDS has slowed, amid a funding shortfall and donor fatigue. In this book, Bjørn Lomborg brings together research by world-class specialist authors, a foreword by UNAIDS founding director Peter Piot and perspectives from Nobel Laureates and African civil society leaders to identify the most effective ways to tackle the pandemic across sub-Saharan Africa. There remains an alarming lack of high-quality data evaluating responses to HIV. We still know too little about what works, where and how to replicate our successes. This book offers the first comprehensive attempt by teams of authors to analyze HIV/AIDS policy choices using cost-benefit analysis, across six major topics. This approach provides a provocative fresh look at the best ways to scale up the fight against this killer epidemic UR - https://doi.org/10.1017/CBO9781139236805 ER -